Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include GlobeNewswire, Reuters, Endpoints News and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 92d ago.
Quick answers
Why is "Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (6)
- Ipsen to pay $1.75B for Kartos and its blood cancer asset FirstWord Pharma · 92d ago
- Ipsen to acquire Kartos Therapeutics, expanding hemato-oncology late-stage pipeline GlobeNewswire · 92d ago
- French biotech company Ipsen to buy Kartos Therapeutics for $450 million Reuters · 92d ago
- Ipsen to buy blood cancer company Kartos Therapeutics for $450M upfront Endpoints News · 92d ago
- Ipsen pens $1.7B deal to acquire Kartos for potential Jakafi add-on therapy for myelofibrosis Fierce Biotech · 92d ago
- Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion WSJ · 92d ago
Topics
Related trends
Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
OpenAI Targets $30 Billion in New Funding at $1.4 Trillion Value
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Kehinde Wiley Wants to Buy His Embassy Painting Back From Trump
Artist Kehinde Wiley attempts to purchase his artwork back following its removal from a U.S. embassy.
Paramount Woos Investors With $44 Billion Debt Offer To Fund WBD Deal As Judge Weighs Settlement
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Warburg Pincus Makes Improved $1.5 Billion Offer for Australia’s Ingenia
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
US Ambassador Pressed Bulgaria to Buy LNG Through Greek Company
2 news sources are covering this World story right now — PULSE is tracking how fast it spreads.